Global Lab Capabilities Pharma Biotech



Similar documents
C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

Catalog. Global Education. and Training. Global Expertise Trusted Standards Improved Health

Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements

Working with ICH Quality Guidelines - the Canadian Perspective

NEW CHEMICAL ENTITIES

Guidance for Industry

EXTRACTABLES AND LEACHABLES FOR MEDICAL DEVICES: MEETING THE 510 (k) REQUIREMENTS

Post-Approval Change Management: Challenges and Opportunities An FDA Perspective

Blood, Plasma, and Cellular Blood Components INTRODUCTION

SERVICES FOR. Devices and Combination Products

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

Microbiology and Auditing. Don Singer

Implementing New USP Chapters for Analytical Method Validation

Regulations for Handling Samples and Laboratory Testing from R&D through Phase III Clinical Trials

Valentina Gualato, Ph.D. Process Development Scientist

Overview of Drug Development: the Regulatory Process

Expectations for Data to Support Clinical Trial Drugs

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants

Biotechpharma company profile

How To Test For Leachables

Extemporaneously Prepared Early Phase Clinical Trial Materials

PHARMACEUTICAL REFERENCE STANDARDS

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry

Introduction to Enteris BioPharma

Pharmaceuticals Production Services Boehringer Ingelheim. Our expertise in world-class contract manufacturing for your success

USP s mission is to improve global health through public. standards and related programs that help ensure the quality,

Library Guide: Pharmaceutical GMPs

GMP Pharma BV. Netherlands

Guidance for Industry

Annex 7 Guidelines on pre-approval inspections

Annex 6. Guidance on variations to a prequalified product dossier. Preface

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

Guidance for Industry

Workshop B Control Strategy

Presented at: Jefferies 2015 Global Healthcare Conference

Micromyx. Micromyx. A Microbiology Services Company. Lab Services Research - Consulting -

Elastomeric Components for Pharmaceutical Applications - Actual Quality Trends - Claudia Petersen. -Senior Manager Biotechnology-

IMPURITIES IN NEW DRUG PRODUCTS

PEOPLE > SCIENCE > SOLUTIONS

The Facts on Equine Drug Testing

Guidance for Industry

Guidance for Industry

Highly Potent APIs The right platform, people and procedures for successful development and manufacturing

ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products

Global experts in Remediation, Auditing, GMP Compliance, Education and Regulatory Affairs for the Pharma and Biotech Industry

Engineering Nanomedical Systems

GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS.

Selvita Integrated drug discovery collaborations

EUROPASS DIPLOMA SUPPLEMENT

USP Pharmaceutical Ingredient Supplier Qualification Program. Manual for Participants

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

Regulation and Risk Management of Combination Products

Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP

Biopharmaceutical Process Evaluated for Viral Clearance

Technology Transfer of CMC Activities for MAb Manufacturing ge healthcare (

Guidance for Industry

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion

Journal of Chemical and Pharmaceutical Research

Introduction to Drug Naming. Angela G. Long, M.S. Senior Vice President, Global Alliances and Organizational Affairs

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.

An Industry White Paper

School of Pharmacy TEMPLE UNIVERSITY

Non-clinical development of biologics

CTC Technology Readiness Levels

FOOD AND DRUG ADMINISTRATION COMPLIANCE PROGRAM GUIDANCE MANUAL

POST-MASTER S CERTIFICATES in ADVANCED QUALITY ASSURANCE or REGULATORY AFFAIRS

Veterinary Compounding

Ph.D. Science & Engineering Positions. Wilmington, DE. Analytical Sciences Wilmington, DE. Sciences Wilmington, DE.

Roles & Responsibilities of the Sponsor

Copyright 2014 The International Pharmaceutical Excipients Council

Changes to an Approved Product

Pharmaceutical Quality Systems: US Perspective

Proficiency Testing In A Global Analytical Environment Benefits & Challenges. AOAC September 2007

Drug Information Journal, Vol. 33, pp , /99

USP CONVENTION MEMBERS BY WORLD REGION

2010 Critical Thinker Series

A FDA Perspective on Nanomedicine Current Initiatives in the US

PRODUCT DEVELOPMENT GUIDE

Importing pharmaceutical products to China

Regulatory Expectations for GMP: What s Happening. Patricia Weideman, PhD Director, Product Quality & Occupational Toxicology Genentech, Inc.

Pharmaceutical Auditor Training

VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1)

How To Understand The Pharmacology Of The Pharmaceutical Industry

Luca Romagnoli, Ph.D. Business Development Manager

Bioprocessing Media and Buffers Grow with Us

Guidance for Industry

Considerations in Setting Specifications

The Use of Enzymes in Dietary Supplements USP Enzyme Workshop July 8, 2009

Media fills Periodic performance qualification (Re-Validation)

Pharmaceutical Sciences

Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing

The Quality System for Drugs in Germany

Workshop A Design Space (DS)

TYPICAL FDA COMMENTS ON IMPURITY PROFILING IN CTD/CEP/DMF SUBMISSIONS

2Technical Support 3Formulation Development 4Proof of Concept 5 GMP Services 6Advanced Drug Delivery 1EUDRAGIT Products Evonik. Power to create.

United States Pharmacopeia (USP) Quality Standards for Dietary Supplements. Nandu Sarma, PhD, RPh. Director, Dietary Supplements

A Preliminary Proposal for a Pharmaceutical Engineering Graduate Program

Transcription:

Global Lab Capabilities Pharma Biotech NSF Health Sciences global network of laboratories delivers expert solutions to pharmaceutical, biotechnology and medical device companies in the areas of analytical testing, regulatory consulting, research and development, and regulatory submissions. www.nsf.org

About NSF International NSF International is a global independent organization that writes standards, and tests and certifies products for the food, water and consumer goods industries to minimize adverse health effects and protect the environment (nsf.org). Founded in 1944, NSF is committed to protecting human health and safety worldwide. NSF International is a Pan American Health Organization/World Health Organization Collaborating Center on Food Safety, Water Quality and Indoor Environment. Our Services NSF supports the global pharmaceutical marketplace, including regulators, manufacturers and consumers of pharma, biotech, medical/combination devices and single-use systems, in the development of innovative products by providing expert support services from preclinical activities to post-market changes. Our global network of accredited labs and industry experts help bring safe products to market and assure that projects are completed to your satisfaction and on time. NSF has more than 2,100 experienced professionals including microbiologists, toxicologists, chemists, engineers and experts in public health. Our Labs Our global network of labs utilize QA systems and maintain strategic accreditations such as ISO/IEC 17025. Our Bristol lab operates as an independent GLP and GMP contract laboratory, which is U.S. FDA registered and U.S. DEA licensed. Other lab accreditations include INMETRO/MAPA/REBLAS/ANVISA (Brazil); CMA/CMAF (China); and Authorized laboratory for Quality Control in Pharmaceutical Members of Official Networks Laboratory by the National Institute of Health-INS (Peru). For accreditations specific to each lab, please see the lab profiles. NSF s scientific knowledge, technical expertise, lab capabilities and customer service enable us to manage the most challenging projects and to assure that your projects are completed to your satisfaction and on time.

Bristol, CT Shanghai, China Lima, Peru Porto Alegre, Brazil NSF Locations NSF Partner Locations Services NSF delivers expert support services from preclinical activities to phase I-IV clinical trials, pharmaceutical development, bioanalytical, protein characterization, biosafety and quality control testing of small and large molecules, raw materials, finished products, containers and utilities. Preclinical - The preclinical tests evaluates safety parameters and effectiveness of pharmaceuticals, through toxicology studies conducted to determine the degree of toxicity and potential reversibility or irreversibility of a chemical substance, to establish the relationship between dose and adverse effects, and to provide information on target organs and target functions. This allows a meaningful assessment of the data obtained and a scientifically supported extrapolation of the effects to the human situation. Clinical NSF provides analysis of small molecule, protein and oligonucleotide therapeutics in plasma, serum and urine through all stages of clinical development. Our scientists routinely validate methods to FDA and other regulatory guidance. NSF is able to identify and analyze for drug metabolites. CMC Analytical NSF develops and validates methods for drug purity, drug content, degradation products and impurities. We routinely perform these methods, compendial methods and microbiological testing in GMP compliance. Our labs perform extractable and leachables studies to assess risk from container closure systems and process equipment.

Preclinical Brazil USA Peru China Toxicology test design Toxicological testing Toxicological evaluation Formulation development Formulation analysis Bioanalytical method development and validation (animal) Plasma (animal) specimen analysis Metabolite Identification Clinical Bioanalytical method development and validation (human) Plasma (human) specimen analysis Metabolite identification CMC Analytical Develop and validate methods for assays and impurities/degradants Analytical testing to support stability Forced degradation Compendia testing (USP, EP, BP) Identification analysis for active pharmaceutical ingredient Microbiological testing Extractables from container closure system Leachables from container closure system into drug product Drug product release testing Dissolution testing Visible and sub visible particles Sampling lots Pharmaceutical packaging compatibility

The right people. The right solution. The first time. www.nsf.org LPH-339-1015 LPH-308-0915

Lab Profile NSF Bioensaios Porto Alegre, Brazil Services: Physical-Chemical Testing Studies in compliance with GLP following ANVISA and ICH guidelines Method development and validation for assay, impurities and degradation products for drugs in compliance with GLP Compendia testing (USP, EP, BP) Forced degradation testing Investigation of impurities: Identification of unknown impurities and degradation products Toxicological Testing Testing following ANVISA, FDA, EMA, ICH and OECD guidance and in compliance with GLP Testing development Microbiological Testing Testing in according to USP and European pharmacopeia Size: 12,000 square feet (1,115 square meters) Established: 1990 Employees: 70+ Accreditations: GLP OECD ISO/IEC 17025 (CGCRE - Coordenação Geral de Acreditação do INMETRO) MAPA - Agriculture Ministry (Veterinary Medical) ANVISA/REBLAS - Health Agency Site Manager: Ellen Martha Pritsch, Director of Business Operations Address: Rua Palermo 257 - CEP 94480-775 - Viamão - Brazil Phone: (55) 51 3493 6888 Email: comercial.farma@nsf.org The right people. The right solution. The first time. LPH-340-1015

Lab Profile NSF Health Sciences Bristol, CT, USA Services: Preclinical and Clinical Support Services for Pharmaceuticals Preclinical study design, consultation and monitoring Preclinical formulation development and analysis Bioanalytical methods development, validation and sample analysis GMP Analytical Testing for Pharmaceuticals and Medical Devices Method development and validation for assay, impurities and degradation products for drugs and combination medical devices Support stability studies, process development and release of finished product USP testing Identification of unknown impurities and degradation products Extractables and Leachables Testing for Pharmaceuticals, Medical Devices and Single-Use Manufacturing Equipment Material Assessment and study design Controlled extraction studies Leachables analysis for drug product container closure systems Size: 15,000 square feet (1,400 square meters) Established: 2000 Employees: 30 Accreditations: GLP and GMP contract laboratories U.S. FDA registered U.S. DEA licensed Site Manager: Kurt Moyer, Ph.D., Director of Research Address: 719 Middle Street, Bristol, CT USA 06010 Phone: 860.940.6550 Email: hstesting@nsf.org The right people. The right solution. The first time. LPH-341-1015

Lab Profile NSF INASSA Lima, Peru Services: Physicochemical and Microbiological Testing for Pharmaceutical Dosage Forms Solid, semisolid and liquid According to regulations: USP / BP / EP Physicochemical Analysis Organoleptic analysis Basic analysis (ph, volume, average weight, density) Quantitative analysis of active ingredients APIs by HPLC, GC, UV-VIS, IR, AAS, Potentiometry, Volumetry and Polarimetry Identification analysis of APIs by TLC, IR and Chemical Reactions Complementary analysis of dosage forms Dissolution, Disintegration, Visible strange particles, Count test of Subvisibles particles for obstruction of light and Microscopy, content of water for KF Microbiological Analysis According to regulation: USP / BP / EP: Standard plate count, test for specific microorganisms, sterility test, Microbiological assays of antibiotics, Bacterial Endotoxins test, Antimicrobial effectiveness test, growth promotion testing media Size: According to AOAC, PREN 12054 and NF EN 1040: Bacterial activity in soaps, Disinfectants, Germicidal and Detergents actions and Basic Quantitative assay of bactericidal activity of chemical disinfectants and antiseptics 33,260 square feet (3,090 square meters) Established: 1981 Employees: 220+ Accreditations: Authorized laboratory for Quality Control in Pharmaceutical Members of Official Networks Laboratory in Peru by the National Institute of Health (INS). ISO/IEC 17025 INACAL (Instituto Nacional de Calidad) Site Manager: Carmen Catter, General Manager Address: Av. La Marina 3035 San Miguel Lima Phone: 511(6165200) Email: inassa@nsf.org The right people. The right solution. The first time. LPH-342-1015

Lab Profile NSF Shanghai Testing Company Shanghai, China Services: Extractables and Leachables Testing for Pharmaceutical Packaging Materials and Medical Devices Material assessment and study design Controlled extraction studies Leachables analysis for drug product container closure systems Compatibility Studies Between Pharmaceutical Packaging and Pharmaceuticals Guidelines of Evaluating Compatibility between Pharmaceutical Packaging and Pharmaceuticals (YBB00142002) Guidelines of Evaluating Compatibility between Chemical Injectables and Polymer Packaging Guidelines of Evaluating Compatibility between Injectables and Glass Packaging cgmp Audit and Analytical Testing for Dietary Supplements cgmp audited following FDA 21 CFR 111 for dietary supplement industry Test method development and validation for ingredient and contaminants in dietary supplements CHP/USP/EP testing Size: 13,600 square feet (1,260 square meters) Established: 2010 Employees: 30 Accreditations: CNAS (ISO/IEC 17025) CMA (China Metrology Accreditation) CMAF (China Metrology Accreditation for Food) Site Manager: Ms. Dongjing Liu, Laboratory Site Manager Address: Unit D/F, 1 Floor, Building 10 Pujiang Intelligence Valley, 1188 Lian Hang Road Shanghai, P.R. China 201112 Phone: +86-21-2428 6300 Email: dliu@nsf.org The right people. The right solution. The first time. LPH-343-1015